Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial.
Buse JB, Bain SC, Mann JFE, Nauck MA, Nissen SE, Pocock S, Poulter NR, Pratley RE, Linder M, Monk Fries T, Ørsted DD, Zinman B; LEADER Trial Investigators.
Buse JB, et al. Among authors: linder m.
Diabetes Care. 2020 Jul;43(7):1546-1552. doi: 10.2337/dc19-2251. Epub 2020 May 4.
Diabetes Care. 2020.
PMID: 32366578
Free PMC article.
Clinical Trial.